The Cooper Companies, Inc.

NASDAQ:COO

Medical - Instruments & Supplies

Healthcare
$60.75 -3.42%

-$2.30 today

Market cap
$11.55B
Beta
0.87
P/E (TTM)
53.8
EPS (TTM)
$1.21
52W Low $58.89High $89.83

Volume 2.20M

Average 2.55M

COO Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

The Cooper Companies, Inc.NASDAQ: COO

Accounts Payables · Q3 FY2026 · quarter ended Jul 2026

Accounts payables outflow grows to $0

Q3 FY2026 accounts payables was $0, compared with $0 a year earlier. Trailing-twelve-month accounts payables was $0. Over 3 fiscal years it compounded at -45.7% a year.

Context

  • Accounts payables amounted to 0.2% of revenue in FY2025, unchanged from a year earlier.
  • Accounts payables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly accounts payables holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJul 2026
$0— QoQ
Last fiscal yearOct 2025
$8M-14.0% YoY
LTMJul 2026
$0— YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-14.0%——
3-year CAGR-45.7%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
8M USD
Year-over-year change
-14.0%

Accounts Payables vs competitors

How COO compares with its peers on the latest reported figures

  • COO's LTM Jul 2026 accounts payables of $0 is the smallest of the 6 companies compared; the peer median is $18.49M.
  • Accounts payables amounts to 0.0% of revenue for COO, versus a peer median of 0.9%.
COO Competitors Peer median
Accounts Payables for COO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BLCOBausch + Lomb CorporationLTM Jun 2026$33.86M -44.5%-17.0%0.6%
GKOSGlaukos CorporationLTM Jun 2026$21.13M +4575.2%+37.7%3.4%
ALCAlcon Inc.LTM Sep 2026$18.49M -52.0%—0.2%
LNSRLENSAR, Inc.LTM Mar 2026$7.34M +97.9%+68.2%12.7%
STAASTAAR Surgical CompanyLTM Apr 2026$2.5M -66.2%—0.9%
COOThe Cooper Companies, Inc.LTM Jul 2026$0 —-45.7%0.0%
Peer median (excluding COO) $18.49M-44.5%+37.7%0.9%

Competitors are the stored peer set for COO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Net Income2.94B385.8M294.2M392.3M374.9M
Depreciation & Amortization309.3M346.1M367.7M375.1M423M
Deferred Income Tax(2.5B)53.9M44.7M118.9M135.2M
Stock-Based Compensation00000
Change in Working Capital(149.9M)(174M)(218.8M)(333.7M)(284.8M)
Accounts Receivables(75.5M)(33.8M)(60.2M)(117.1M)(120.3M)
Inventory(9.2M)(40.4M)(105.4M)(59.3M)(46M)
Accounts Payables(16M)49.9M5.5M9.3M8M
Other Working Capital(49.2M)(149.7M)(58.7M)(166.6M)(126.5M)
Other Non-Cash Items136.7M80.6M119.7M156.7M147.8M
Operating Cash Flow738.6M692.4M607.5M709.3M796.1M
Capital Expenditures(214.4M)(242M)(392.5M)(421.2M)(362.4M)
Acquisitions (Net)0(1.59B)(56.5M)(343.4M)(10.5M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(235.9M)0000
Investing Cash Flow(450.3M)(1.83B)(449M)(764.6M)(372.9M)
Debt Repayment(309.9M)1.28B(180.8M)5.6M(79.9M)
Common Stock Issued26.3M16.1M23M63.9M16M
Common Stock Repurchased(24.8M)(78.5M)00(290.1M)
Dividends Paid(3M)(3M)(3M)00
Other Financing Activities0(19.7M)(13.1M)(30.3M)(71.9M)
Financing Cash Flow(311.4M)1.19B(173.9M)39.2M(425.9M)
Effect of Forex Changes2.6M(12.6M)(2.3M)2.9M5.6M
Net Change in Cash(20.5M)42.3M(17.7M)(13.2M)2.9M
Free Cash Flow524.2M450.4M215M288.1M433.7M

The Cooper Companies, Inc.

NASDAQ:COO

Intrinsic Alpha fair value

Locked

Current Price

$60.75

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.